Attached files

file filename
EX-10.1(B) - AMENDMENT TO INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED DECEMBER 5, 2019 - Ensysce Biosciences, Inc.f10k2019ex10-1b_leisureacqu.htm
10-K - ANNUAL REPORT - Ensysce Biosciences, Inc.f10k2019_leisureacqu.htm
EX-32.1 - CERTIFICATION - Ensysce Biosciences, Inc.f10k2019ex32-1_leisureacqu.htm
EX-31.2 - CERTIFICATION - Ensysce Biosciences, Inc.f10k2019ex31-2_leisureacqu.htm
EX-31.1 - CERTIFICATION - Ensysce Biosciences, Inc.f10k2019ex31-1_leisureacqu.htm
EX-10.12 - EXPENSE ADVANCE AGREEMENT, DATED DECEMBER 5, 2019, BETWEEN THE COMPANY AND GTWY - Ensysce Biosciences, Inc.f10k2019ex10-12_leisureacqu.htm
EX-10.6(B) - AMENDMENT TO LETTER AGREEMENT, DATED DECEMBER 5, 2019 - Ensysce Biosciences, Inc.f10k2019ex10-6b_leisureacqu.htm
EX-4.5 - DESCRIPTION OF REGISTRANT'S SECURITIES - Ensysce Biosciences, Inc.f10k2019ex4-5_leisureacqu.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Leisure Acquisition Corp. (the “Company”) on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, George Peng, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: March 10, 2020 By: /s/ George Peng
    George Peng
   

Chief Financial Officer 

(Principal Financial and Accounting Officer)